Cellectis Competitors and Similar CompaniesClear all
Cellectis's competitors and similar companies include Allogene Therapeutics.
 Cellectis Cellectis is a clinical-stage biopharmaceutical company that develops cell and gene therapies. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | |
Founding Date | Founding Date 1999 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Paris, FR HQ New York, US Raleigh, US | Locations South San Francisco, US HQ |
Employees | Employees 216 | Employees 2263% decrease |
Valuation ($) | Valuation ($) 189.4 m | Valuation ($) 585.5 m |
Financial | ||
Net income | Net income ($67.6m) (FY, 2025) | Net income ($190.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 3.2m | Total funding raised $ 532m |
For sources of this data, please see the company profile
View Company Profiles
Allogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company